Order results by:
| Issue | Title | |
| Vol 19, No 2 (2023) | Evolution of CHA2DS2-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation | Abstract similar documents |
| A. O. Rubanenko | ||
| "... scores that predict stroke risk,butthe most popular is CHA2DS2-VASc risk score. At the same time ..." | ||
| Vol 14, No 6 (2018) | Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice | Abstract PDF (Eng) similar documents |
| K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova | ||
| "... .9%) – pernanent. Results. While assessing the risk of thromboembolic complications on the CHA2DS2-VASc scale ..." | ||
| Vol 19, No 2 (2023) | Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? | Abstract similar documents |
| I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva | ||
| "... DS2-VASc-RAF, mCHA2DS2-VASc, CHA2DS2-VASc-AFR, ATRIA scores were evaluated and compared as potential ..." | ||
| Vol 21, No 2 (2025) | Gender-specific aspects and contemporary assessment of thromboembolic complications in atrial fibrillation (literature review) | Abstract similar documents |
| D. V. Duplyakov, L. V. Shekhovtsova, D. A. Shebonkina | ||
| "... in patients with atrial fibrillation (AF), with a focus on the role of gender in the CHA2DS2-VASc score, which ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... from the hospital. The risk of ischemic stroke was assessed using the CHA2DS2-VASc score, and the risk ..." | ||
| Vol 15, No 1 (2019) | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... was performed. Results. All patients were stratified in three groups depending on the CHA2DS2-VASc score ..." | ||
| Vol 8, No 5 (2012) | RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman | ||
| "... with the CHADS2 and CHA2DS2–VASc scales and appointed ATT was analyzed. Results. Patients with high risk of TEC ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... by means of the CHA2DS2-VASc score and HAS-BLED score, respectively. Presence of comorbid diseases ..." | ||
| Vol 17, No 2 (2021) | Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran | Abstract PDF (Eng) similar documents |
| N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev | ||
| "... .8, and CHA2DS2VASc score - 3.8. During the observation period, there were 3 cases of major bleeding and 133 ..." | ||
| Vol 17, No 2 (2021) | Laboratory predictors of clinical outcomes in patients with atrial fibrillation | Abstract similar documents |
| A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov | ||
| "... positively correlate with the CHA2DS2 and CHA2DS2-VASC scales of stroke risk stratification. The analysis ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... of AF. CHA2DS2-VASc score was used in all patients for calculation the risk of ischemic stroke ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... into account the baseline PRECISE-DAPT scores. Material and methods. The study included 680 patients with MI ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... Aim. To study the prognostic value of the ORACLE risk score for assessing the risk of bleeding ..." | ||
| Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
| "... , 38 women); 3rd – elder than 65 y.o. (11 men, 34 women). Fatal CV risk according to SCORE scale ..." | ||
| Vol 20, No 2 (2024) | Clinical and prognostic value of the MELD-XI score in hospitalized patients with chronic heart failure | Abstract similar documents |
| N. A. Dragomiretskaya, V. I. Podzolkov, A. V. Tolmacheva, I. I. Shvedov, M. V. Vetluzhskaya, V. D. Chistyakova | ||
| "... -acquired pneumonia. Each subsequent 1-point increase in MELD-XI score increases the odds of death by 1 ..." | ||
| Vol 14, No 3 (2018) | ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| D. B. Nemik, G. V. Matyushin, S. A. Ustyugov | ||
| "... practice, the most common method of assessing such lesions is the SYNTAX Score scale. Aim. To study ..." | ||
| Vol 21, No 2 (2025) | Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation | Abstract similar documents |
| E. A. Naryshkina, M. I. Chashkina, E. S. Zadykyan, N. K. Kurnabalieva, E. M. Zakaryan, M. V. Serova, D. A. Andreev, A. G. Komarova, K. E. Eroshkin, A. A. Kulesh, D. A. Sychev | ||
| "... (n=9). The mean patient age was 77.8 years, with an average CHA2DS2-VASc score of 6. In 33 ..." | ||
| Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
| A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
| "... of electronic version of the SCORE scale in primary care. Material and methods. 300 hypertensive patients ..." | ||
| Vol 12, No 3 (2016) | THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE | Abstract PDF (Eng) similar documents |
| A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko | ||
| "... according to CHA2DS2-VASc points amount but it did not reach the statistical significance (r=0.620, p=0 ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... groups were comparable in risk score by CHA2DS2-VASc and HAS-BLED scales. Results. Patients with AF (n ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... fibrillation (AF) was analyzed with CHA2-DS2-VASc score. Results. Appearance of recommendations for the direct ..." | ||
| Vol 14, No 6 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety | Abstract PDF (Eng) similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... no significant differences in age, sex, AF duration, concomitant cardiovascular diseases, CHA2DS2-VASc score ..." | ||
| Vol 17, No 6 (2021) | Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 | Abstract similar documents |
| A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov | ||
| "... included 263 case histories in 2012, 502 ones in 2016 and 524 in 2020. CHA2DS2-VASc score was used ..." | ||
| Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
| A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
| "... patients had an assessment of the risk of thromboembolic complications on the CHA2DS2-VASc scale, the risk ..." | ||
| Vol 13, No 2 (2017) | ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC | Abstract PDF (Eng) similar documents |
| E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov | ||
| "... .6), CHA2DS2-VASc and HAS-BLED score were estimated as 5.14Ѓ}1.50 и 1.59Ѓ}0.79, respectively ..." | ||
| Vol 21, No 1 (2025) | Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment | Abstract similar documents |
| A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov | ||
| "... to cardiovascular risk stratification using the SCORE-2 scale and the likelihood of familial hypercholesterolemia ..." | ||
| Vol 13, No 4 (2017) | PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) | Abstract similar documents |
| M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov | ||
| "... %, and 29%, respectively. The risk score according to the CHA2DS2-VASc and HAS-BLED scales was higher ..." | ||
| Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract similar documents |
| S. G. Kanorskii | ||
| "... , 329 days. The mean CHADS2 and CHA2DS2-VASc scores were 2.0 and 3.4, respectively. Treatmentemergent ..." | ||
| Vol 10, No 2 (2014) | ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Maslakov | ||
| "... were stratified into three groups depending on the value of the index CHA2DS2-VASc. Antithrombotic ..." | ||
| Vol 6, No 3 (2010) | BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS | Abstract similar documents |
| J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal | ||
| "... гиперхолестеринемии у взрослых (Adult Treatment Panel III — ATP III); emшкалы/em emSCORE/em (Systematic COronary Risk ..." | ||
| Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
| R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
| "... duration was 7.6Ѓ}2.0 years. The average emscore/em of emCHA/em2DS2-emVASc/em was 3.4Ѓ}1.4. Results. Less than 70 ..." | ||
| Vol 14, No 5 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... diseases, emCHA/em2DS2-emVASc/em emscore/em and echocardiographic parameters between the groups compared. Initial ..." | ||
| Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
| "... characteristics and thromboembolic risk levels according to emCHA/em2DS2-emVASc/em scale. Results. Treatment duration before ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... . The high risk according to emCHA/em2DS2-emVASc/em scale was revealed in 96.3% of patients and according to HAS-BLED ..." | ||
| Vol 11, No 5 (2015) | New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation | Abstract similar documents |
| article Editorial | ||
| "... умеренного (emCHA/em2DS2-emVASc/em=1) риска • Анализ первых двух лет наблюдения из продолжающегося постмаркетингового ..." | ||
| Vol 15, No 5 (2019) | Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... points on the emCHA/em2DS2emVASc/em scale – 67.0% and 91.7%, heart rate 90/min – 68.8% and 100% of patients ..." | ||
| Vol 17, No 3 (2021) | New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract PDF (Eng) similar documents |
| A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov | ||
| "... formula for first visit and 15th month’s follow-up. Results. The median emscore/em of emCHA/em2DS2VASс scale was 4 ..." | ||
| Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
| "... observation of patients 75 years and older with very high thromboembolic risk (emCHA/em2DS2-emVASc/em – 4,5 points ..." | ||
| Vol 17, No 5 (2021) | Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... ; 43.1% of men; emCHA/em2DS2-emVASc/em – 4.57±1.61 points; HAS-BLED – 1.60±0,75 points), and the group with AF ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... 0.05), despite of the higher СНА2DS2-emVASc/em risk emscore/em (4.69±1.66 and 4.23±1.57 vs 3.81±1.69; р0 ..." | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... . The risk of stroke and systemic embolism was 4,7±1,5 (emCHA/em2DS2-VASс), 97,5% of patients with non-valve AF ..." | ||
| Vol 18, No 3 (2022) | Modern Approaches to the Interpretation of the Results of Large Randomized Clinical Trials | Abstract similar documents |
| S. R. Gilyarevsky | ||
| Vol 7, No 5 (2011) | PSYCHOMETRIC VISUAL ANALOGUE SCALE IN ASSESSMENT OF THE STABLE ANGINA SEVERITY AND EFFICACY OF ANTIANGINAL THERAPY | Abstract similar documents |
| E. V. Solyanik | ||
| "... Цель. Оценить возможности использования психометрических визуально–аналоговых emшкал/em (ВАШ) в оценке ..." | ||
| Vol 12, No 1 (2016) | The Moriscos-Green scale: the pros and cons of universal test, correction of mistakes | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko | ||
| "... -вопросная emшкала/em Мориски-Грина. Оцениваются достоинства (универсальность, лаконичность) и недостатки ..." | ||
| Vol 17, No 6 (2021) | The Scale of Quantitative Assessment Adherence to Treatment «QAA-25»: Updating of Formulations, Constructive and Factor Validity and a Measure of Consent | Abstract PDF (Eng) similar documents |
| N. A. Nikolaev, Yu. P. Skirdenko, A. A. Balabanova, A. V. Gorbenko, K. A. Andreev, M. M. Fedorin, M. A. Livzan, E. V. Chebanenko, G. M. Usov | ||
| "... Цель. Актуализировать формулировки отдельных вопросов emшкалы/em вопросника количественной оценки ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... using Propensity emScore/em Matching. Material and methods. 262 patients aged 60.1±8.9 years, taking statins ..." | ||
| Vol 14, No 6 (2018) | P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva | ||
| Vol 17, No 4 (2021) | The Questionnaire Survey Method in Medicine on the Example of Treatment Adherence Scales | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina | ||
| "... Цель. Разработка, апробация и валидизация оригинального опросника – emшкалы/em приверженности (ШП) в ..." | ||
| Vol 16, No 6 (2020) | Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome | Abstract similar documents |
| R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh | ||
| "... all patients with ACS at the inpatient stage of treatment is used the PRECISE DAPT emscore/em. In order ..." | ||
| Vol 7, No 3 (2011) | COGNITIVE-MNESTIC FUNCTIONS IN ABLE-BODIED AGED PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION IN AMLODIPINE TREATMENT | Abstract similar documents |
| N. N. Ilov, R. N. Shvarts, T. N. Panova | ||
| "... . Cognitive deficiency grade correlated positively with BP elevation degree: a total MMSE emscore/em is higher ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... was calculated by the emSCORE/em and PROCAM scales. Results. The incidence of arterial hypertension ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
| M. N. Kovrigina, M. N. Mamedov | ||
| "... , hypercholesterolemia) and various CV risk (emSCORE/em) were included in the one- stage clinical trial. All patients were ..." | ||
| Vol 16, No 6 (2020) | Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... with chronic noncardiac diseases (81.5% vs 63.5%, p0.0001), the risk of thromboembolic complications (emCHA/em2DS2 ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... a higher risk of thromboembolic complications (emCHA/em2DS2-emVASc/em – 4.68±1.59 and 3.10±1.50; p0 ..." | ||
| Vol 11, No 3 (2015) | CLINICAL ASPECTS OF PATIENT SELECTION FOR CORONARY ANGIOGRAPHY IN NON-ST ELEVATION ACUTE CORONARY SYNDROME | Abstract similar documents |
| K. A. Kireev | ||
| Vol 14, No 4 (2018) | Main Approaches to Assessing the Quality of Drug Therapy in Cardiology | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, N. A. Komkova, N. A. Dmitrieva, O. A. Drapkina | ||
| "... назначенного лекарственного средства. Также проводится обзор разработанных к настоящему времени методов и emшкал/em ..." | ||
| Vol 4, No 5 (2008) | CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| D. A. Poddubnyy, A. P. Rebrov | ||
| "... of fatal cardiovascular event (emSCORE/em scale) was calculated. Additionally the follows cardiovascular risk ..." | ||
| Vol 7, No 3 (2011): | РЕКОМЕНДАЦИИ ПО РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА | Abstract similar documents |
| , , , , , , , , , , , , , , , , , , , , , , , , | ||
| Vol 13, No 2 (2017) | FALLING OF SENILE AGE PATIENT AS AN ADVERSE EVENT ASSOCIATED WITH THE USE OF MEDICINES: CASE REPORT | Abstract similar documents |
| E. S. Ilina, O. T. Bogova, S. V. Gorbatenkova, D. A. Sychev | ||
| "... взаимодействием лекарственных средств (по emшкале/em Horn-Hansten). ..." | ||
| Vol 18, No 5 (2022) | The Role of Structured Telephone Support in the Development of Self-care in Comorbid Patients with Chronic Heart Failure | Abstract PDF (Eng) similar documents |
| E. D. Kartamysheva, Yu. M. Lopatin | ||
| "... months, total SCHFI emscores/em increased significantly by 62% in the telephone support group and by 34 ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... cardiovascular risk by 38.1%. In the absence of preventive measures cardiovascular risk, predicted by the emSCORE/em ..." | ||
| Vol 17, No 5 (2021) | Assessment of the Severity of Breast Artery Calcification on a Mammogram: Intraoperator and Interoperator Reproducibility | Abstract similar documents |
| E. V. Bochkareva, E. K. Butina, N. Kh. Bayramkulova, O. A. Abdalova, V. A. Kutsenko, O. M. Drapkina | ||
| "... reproducibility of the total emscore/em for each mammary gland, the exact coincidence of the results was noted in 70 ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE | Abstract similar documents |
| M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya | ||
| "... cardiovascular risk (emSCORE/em scale 5%) aged 30-59 y.o. were included in the study. Questionnaire survey, blood ..." | ||
| Vol 15, No 6 (2019) | Association of Self-Perceived Health with Social and Psychological Environment, the Mode of Life and Cardiovascular Risk Markers in Middle-Aged Men – Residents of Moscow | Abstract PDF (Eng) similar documents |
| M. B. Kotova, V. B. Rozanov, E. I. Ivanova | ||
| "... according to the distribution of SPH rates by tertiles: the group 1 (from 7 to 60 emscores/em) – bad health ..." | ||
| Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
| "... (emSCORE/em2 and emSCORE/em OP) proposed by the European Society of Cardiology and the European Society ..." | ||
| Vol 18, No 4 (2022) | Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels | Abstract PDF (Eng) similar documents |
| O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov | ||
| "... studied in its correlation with the disease severity according to SOFA emscore/em, computer tomographic (CT ..." | ||
| Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
| O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
| "... a very high risk by emSCORE/em scale. Prescribed therapy: SPCs amlodipine/perindopril (54%) and amlodipine ..." | ||
| Vol 5, No 5 (2009) | ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS | Abstract similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina | ||
| "... of depression was associated with good patient knowledge about DM2. Well informed patients had lower emscore/em ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... complications (CVC). Material and methods. 101 patients with HT of 1-2 stage, HH and high risk of CVC (emSCORE/em5 ..." | ||
| Vol 4, No 4 (2008) | EFFICACY OF CHRONIC HEART FAILURE COMBINED THERAPY DURING PERLINDOL USAGE IN ELDERLY POST INFARCTION PATIENTS WITH PSYCHOSOMATIC DISORDERS | Abstract similar documents |
| M. E. Statsenko, I. A. Tyschenko | ||
| "... period normal Beck emscores/em were registered in 90% and mild depression emscores/em - in 10% of patients ..." | ||
| Vol 17, No 6 (2021) | Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 | Abstract similar documents |
| I. S. Yavelov | ||
| "... VTE risk emscore/em with the addition of elevated in-hospital D-dimer level. And the most well-studied ..." | ||
| Vol 16, No 6 (2020) | Assessment of Subclinical Manifestations of Atherosclerosis of Coronary and Peripheral Arteries and Bone Strength Parameters in Women | Abstract PDF (Eng) similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, M. A. Myagkova, V. E. Novikov, O. Yu. Isaykina, O. M. Drapkina | ||
| "... with a high cardiovascular risk, assessed by the emSCORE/em scale, after 45 years and before menopause to detect ..." | ||
| Vol 6, No 4 (2010) | MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION | Abstract similar documents |
| Z. M. Sizova, E. V. Shikh, V. L. Zakharova, E. V. Smirnova | ||
| "... to nicorandil and amlodipine therapy, respectively. General GHQ-28 emscore/em decreased by 54% (р0.05) and 44% (р0 ..." | ||
| Vol 14, No 3 (2018) | TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, L. A. Sokolova, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin | ||
| "... QoL “Disease Perception” emscore/em and more confidence in the doctor (“Treatment Satisfaction” emscore/em) than ..." | ||
| Vol 13, No 6 (2017) | PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
| A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin | ||
| "... emscores/em. Among patients receiving dabigatran initial decrease in von Willebrand factor plasma level (p=0 ..." | ||
| Vol 14, No 1 (2018) | MODERN POSSIBILITIES OF ACHIEVING TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS IN OUTPATIENT PRACTICE: THE LEADER STUDY RESULTS | Abstract similar documents |
| D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, O. M. Drapkina, S. A. Boytsov | ||
| "... the maximum emscore/em on the treatment effectiveness and 97% – on the treatment safety. During the entire ..." | ||
| Vol 4, No 4 (2008) | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN | Abstract similar documents |
| A. A. Kirichenko, Z. M. Tankieva | ||
| "... was estimated as well as psychic status according to emscore/em of depression and anxiety. Results. Office ..." | ||
| Vol 13, No 2 (2017) | FACTORS INFLUENCING THE FORMATION OF BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION | Abstract similar documents |
| Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova | ||
| "... " and "projection" with high values of the emscore/em according to MBI scales were found. Conclusion. Perfectionism ..." | ||
| Vol 16, No 5 (2020) | Thrombolytic Therapy in Normotensive Patients with Pulmonary Embolism (Data from the Retrospective Study) | Abstract similar documents |
| N. A. Сherepanova, I. S. Mullova, A. R. Kiselev, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
| "... , and the severity of PE according to the PESI emscore/em showed no significant impact on this decision. In-hospital ..." | ||
| Vol 21, No 1 (2025) | Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction | Abstract similar documents |
| A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha | ||
| "... and anaemia significantly increased hemoglobin and serum ferritin levels, exercise tolerance, and QoL emscores/em ..." | ||
| Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
| "... .5% of patients. Chest CT scans were obtained in 78 (36.6%) patients, whose worst lung damage emscores/em during ..." | ||
| Vol 15, No 1 (2019) | Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination | Abstract similar documents |
| O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec | ||
| "... .013); and interference emscore/em (from 50.9±19.2 to 43.1±22.0 s; р=0.011); increased MoCA emscore/em (from 28.4±1.3 to 29.4±1.2; р ..." | ||
| Vol 18, No 6 (2022) | Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study | Abstract similar documents |
| F. T. Ageev, M. D. Smirnova | ||
| "... decreased by 0.5%; HC – by 1.5%; body weight – by 0.42% (p0.001 in all cases). emScores/em in patients ..." | ||
| Vol 17, No 3 (2021) | Ability of Evaluation Coronary Calcium Index Based on Ultra-Low-Dose Computed Tomography Used in Moscow Lung Cancer Screening Project | Abstract similar documents |
| A. E. Nikolaev, A. N. Shapiev, O. A. Korkunova, G. Z. Mukhutdinova, P. V. Tkacheva, M. M. Suleymanova, A. N. Shapieva, D. M. Ramazanova, M. N. Rzayev, V. A. Gombolevsky | ||
| "... the CAC-DRS scale (assessment of the degree of calcification by emscores/em from 0 to 3 and the number ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... was performed using GRACE emscore/em. The distribution of the hospital risk mortality were the following: 25 ..." | ||
| Vol 18, No 2 (2022) | Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region) | Abstract similar documents |
| N. N. Nikulina, Yu. V. Terekhovskaya, S. S. Yakushin | ||
| "... , the most common reason for performance was the results of the PESI emscore/em (n=17) and/or a significant amount ..." | ||
| Vol 19, No 5 (2023) | Association of breast arterial calcification and carotid atherosclerosis as a marker of cardiovascular risk | Abstract similar documents |
| E. V. Bochkareva, E. K. Butina, N. Kh. Bayramkulova, I. V. Kim, O. V. Molchanova, E. M. Filichkina, E. B. Yarovaya, V. A. Metelskaya, O. M. Drapkina | ||
| "... was assessed by a 12-point emscore/em. Duplex ultrasound of extracranial arteries determined plaque presence ..." | ||
| Vol 20, No 6 (2024) | Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older | Abstract similar documents |
| S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, V. A. Kutsenko, Yu. A. Balanova, A. V. Kapustina, O. M. Drapkina | ||
| "... ; a decrease in cognitive function corresponded to a sum of emscores/em less than 24 out of 30 points. DHEAS levels ..." | ||
| Vol 21, No 1 (2025) | The main predictors of seasonal blood pressure changes in patients with stable arterial hypertension in Moscow | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov, Ya. N. Koshelyaevskaya, E. V. Platonova | ||
| "... were found: 1) for SBPd — DBPd — 5 scale emscores/em of the QL questionnaire; 3) for DBPn — diastolic white ..." | ||
| Vol 17, No 2 (2021) | Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| M. Yu. Gilyarov, E. V. Konstantinova, M. R. Atabegashvili, T. D. Solntseva, D. A. Anichkov, А. N. Kostina, R. V. Polybin, A. E. Udovichenko, A. V. Svet | ||
| "... PCI was performed in 73% and 32%, respectively. Mean CCI emscore/em was 7.9 points: 7.6 points in men and 8 ..." | ||
| Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
| A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
| "... of cardiac surgery was in 27.6% of patients. All patients had 3 risk factors for ischemic stroke (emCHA/em2DS2 ..." | ||
| Vol 14, No 3 (2018) | RECENT ASPECTS OF CARDIAC REMODELING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| V. V. Lee, N. Yu. Timofeeva, V. S. Zadionchenko, T. V. Adasheva, N. V. Vysotskaya | ||
| "... ultrasound speckle tracking studies have shown the presence of emsub/em-clinical LV systolic dysfunction ..." | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... Infarction Injury emScore/em (CIIS) index was also evaluated. Results. COPD is associated with arterial ..." | ||
| Vol 10, No 2 (2014) | HYPERPHAGIA REACTIONS WITHIN EATING DISORDERS. CLINICAL FEATURES AND THERAPY | Abstract similar documents |
| O. A. Gladyshev | ||
| "... with excellent and good results in 80% of patients. 50%-reduction in HADS emscore/em for anxiety was found in 74 ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... to the generally accepted (standard) vascular risk assessment algorithms Framingham Risk emScore/em and Pooled Cohort ..." | ||
| Vol 17, No 3 (2021) | Prevalence of Musculoskeletal Disorders in Patients with Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, K. E. Krivoshapova, V. L. Masenko, E. A. Wegner, А. N. Kokov, S. A. Pomeshkina, O. L. Barbarash | ||
| "... only in 19.9% of patients with CAD. Among the examined patients with CAD a low T-emscore/em according ..." | ||
| Vol 18, No 1 (2022) | Assessment of Pre-test and Clinical Probability in the Diagnosis of Chronic Coronary Syndrome — What's New? | Abstract similar documents |
| A. N. Sumin, A. V. Shcheglova | ||
| "... хроническом коронарном синдроме (ХКС) был существенно изменен, произведена существенная ревизия emшкалы/em оценки ..." | ||
| Vol 3, No 5 (2007) | EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| I. V. Vologdina | ||
| "... мес лечения регистрировали сумму баллов по emшкале/em оценки клинического состояния (ШОКС), проводили тест ..." | ||
| Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. A. Anichkov, A. A. Platonova | ||
| "... with disease activity emscore/em (DAS28). LF and HF levels depended on age. The analysis of 24-h ECG recordings ..." | ||
| 1 - 100 of 184 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
